Cite

    Azoulay, D. et al. (2020). Brain‐derived neurotrophic factor as a potential biomarker of chemotherapy‐induced peripheral neuropathy and prognosis in haematological malignancies; what we have learned, the challenges and a need for global standardization. British journal of haematology. pp. 17-18. [Online].